Clinical–Liver, Pancreas, and Biliary TractSPINK1/PSTI mutations are associated with tropical pancreatitis and type II diabetes mellitus in Bangladesh☆,☆☆,★
Section snippets
Patients
Patients younger than 40 years of age with a new diagnosis of type II diabetes mellitus between 1996 and 1997 were prospectively selected from the outpatient department of the Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders, a large World Health Organization (WHO) collaborating center in Dhaka, Bangladesh, for the prevention and control of diabetes. All patients underwent a history, physical examination, and oral glucose tolerance test as
Results
The clinical characterization of the patients and controls showed the typical features of patients with FCPD, TCP, and NIDDM and of healthy controls. The primary laboratory findings are summarized in Table 1.
The entire SPINK1 gene and flanking intronic regions were successfully sequenced in all patients and 50 controls. Exon 3 was also successfully sequenced in 26 additional controls. Heterozygous N34S mutations were identified in 1 of 76 controls and 13 of 37 TP patients (11/22 in FCPD
Discussion
SPINK1 serves as an important and specific inhibitor of active trypsin. The role of SPINK1 N34S mutations in predisposing children to pancreatitis was first shown by Witt et al.12 and in familial pancreatitis by Pfützer et al.13 However, the genetics proved complex with pancreatitis seen with both homozygous and heterozygous disease-associated genotypes, even though far less than 1% of N34S carriers express a pancreatitis phenotype.13, 20, 21 Surprisingly, N34S is present in >1% of populations
Acknowledgements
The authors thank all colleagues and staff at the Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders and the Institute of Postgraduate Medicine and Research. Special thanks to Muhmud Hasan, Faruque Pathan, Hassan Ali, Sayeedul Hassan, Nani Gopal Banik, Zafar A. Latif, Tofail Ahmed, M. Anisur Rahman, M. Sumsul Arefin, M. Sawkat Hassan, Motior Rahman, Humayun Kabir Choudhary, Begum Rokeya, Quamrum Nahar, and Shane Ara Begum. The authors also thank
References (33)
- et al.
Chronic cassava toxicity: possible relationship to chronic pancreatic disease in malnourished populations
Lancet
(1973) - et al.
SPINK1/PSTI mutations are associated with tropical pancreatitis in Bangladesh: a preliminary report
Pancreatology
(2001) - et al.
SPINK1 mutations are associated with multiple phenotypes
Pancreatology
(2001) - et al.
SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis
Gastroenterology
(2000) How to think about SPINK and pancreatitis
Am J Gastroenterol
(2002)- et al.
Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations
Gastroenterology
(2001) - et al.
The natural history of pain in alcoholic chronic pancreatitis
Gastroenterology
(1999) - et al.
The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes
Am J Hum Genet
(2000) Cirrhosis and disseminated calcification of the pancreas in patients with malnutrition
Trop Geogr Med
(1959)- et al.
Lack of association between cassava consumption and tropical pancreatitis syndrome
J Gastroenterol Hepatol
(1994)
Familial aggregation in fibrocalculous pancreatic diabetes
Pancreas
HLA antigens in chronic pancreatitis in tropics
Lack of R117H mutation in the cationic trypsinogen gene in patients with tropical pancreatitis from Bangladesh
Pancreas
Pancreatitis in fibrocalculous pancreatic diabetes mellitus is not associated with common mutations in the trypsinogen gene
Diabetes Metab Res Rev
Mutations in cystic fibrosis transmembrane regulator gene in patients with tropical calcific pancreatitis
Am J Gastroenterol
Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene
Nat Genet
Cited by (0)
- ☆
A. Schneider, A. Suman, and L. Rossi contributed equally to this work. N. Gyr and D. C. Whitcomb co-directed this project.
- ☆☆
Address requests for reprints to: David C. Whitcomb, M.D., Ph.D., University of Pittsburgh, Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, Room 571, Scaife Hall, 3550 Terrace Street, Pittsburgh, Pennsylvania 15261. e-mail: [email protected]; fax: (412) 383-7236.
- ★
Supported by the Stanley Thomas Johnson Foundation, Berne, Switzerland; the Novartis and Roche Research Foundations; the Freiwillige Akademische Gesellschaft, Basel, Switzerland; and United States National Institutes of Health grant DK54709 (to D.C.W.); Dr Schneider was supported by the University of Heidelberg.